Effect of peroperative low-dose naloxone infusion on the development of remifentanil-induced shivering.Randomized double-blind study
Not Applicable
- Conditions
- patients who receives remifentanil based anesthesia
- Registration Number
- JPRN-UMIN000013549
- Lead Sponsor
- Department of Anesthesiology Musashikosugi-Hopaital Nippo Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
patients with febrile symptom, aptients who is obese.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method presence of shivering within 2 hours after emergence from remifentanil based ansethesai
- Secondary Outcome Measures
Name Time Method